A community intervention trial of multimodal suicide prevention program in Japan: A Novel multimodal Community Intervention program to prevent suicide and suicide attempt in Japan, NOCOMIT-J
1 Health Center, Keio University,.35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
2 Division of Neuropsychiatry and Center for Dementia, Sendai City Hospital, 3-1 Shimizukouji, Wakabayashi-ku, Sendai 984-8501, Japan
3 Department of Occupational Therapy, Faculty of Nursing and Rehabilitation, Aino University, 4-5-4 Higashiooda, Ibaraki-shi, Osaka 567-0012, Japan
4 Department of Psychiatry, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake-cho, Miyazaki-gun, Miyazaki 889-1692, Japan
5 Division of Preventive Medicine, Department of Community Health and Medicine, esearch Institute, International Medical Center of Japan, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan
6 Aomori Prefectural Center for Mental Health and Welfare, 353-92 Sawabe Sannai, Aomori-shi, Aomori 038-0031, Japan
7 Department of Psychiatry, Kohnodai Hospital, National Center of Neurology and Psychiatry, 1-7-1 Kohnodai, Ichikawa-shi, Chiba 272-8516, Japan
8 Department of Public Health, Akita University School of Medicine, 1-1-1 Hondo, Akita-shi, Akita 010-8543, Japan
9 Department of Psychiatry, Graduate School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
10 Department of Psychiatry, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyusyu-shi, Fukuoka 807-8555, Japan
11 Health Promotion Division of Health and Social Welfare Department, Kagoshima Prefecture, 10-1 Kamoike-shinmachi, Kagoshima-shi, Kagoshima 890-8577, Japan
12 Department of Neuropsychiatry, Iwate Medical University, 19-1 Uchimaru, Morioka-shi, Iwate 020-8505, Japan
13 Department of Social Welfare, Faculty of Health Sciences, Aomori University of Health and Welfare, 58-1 Mase Hamadate, Aomori-shi, Aomori 030-8505, Japan
14 Graduate School of Medicine, Gunma University, 39-22 Showa-machi 3-chome, Maebashi-shi, Gunma 371-8511, Japan
15 Department of Adult Mental Health, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho, Kodaira-shi, Tokyo 187-8553, Japan
16 Stress Management Office, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
17 Kanoya Public Health Center, 2-16-6 Utsuma, Kanoya-shi, Kagoshima 893-0011, Japan
18 Department of Biostatistics, School of Public Health, Kyoto University, Yoshidakonoecho, Sakyo-ku, Kyoto-shi, Kyoto 606-8501, Japan
19 Sensatsu Public Health Center, 228-1 Kumanojocho, Satsumasendai-shi, Kagoshima 895-0041, Japan
20 Department of Psychology, Faculty of Human Sciences, Kansai University of International Studies, 1-18 Aoyama, Shizimi-cho, Miki-shi, Hyogo 673-0521, Japan
BMC Public Health 2008, 8:315 doi:10.1186/1471-2458-8-315Published: 15 September 2008
To respond to the rapid surge in the incidence of suicide in Japan, which appears to be an ongoing trend, the Japanese Multimodal Intervention Trials for Suicide Prevention (J-MISP) have launched a multimodal community-based suicide prevention program, NOCOMIT-J. The primary aim of this study is to examine whether NOCOMIT-J is effective in reducing suicidal behavior in the community.
Methods/DesignThis study is a community intervention trial involving seven intervention regions with accompanying control regions, all with populations of statistically sufficient size. The program focuses on building social support networks in the public health system for suicide prevention and mental health promotion, intending to reinforce human relationships in the community. The intervention program components includes a primary prevention measures of awareness campaign for the public and key personnel, secondary prevention measures for screening of, and assisting, high-risk individuals, after-care for individuals bereaved by suicide, and other measures. The intervention started in July 2006, and will continue for 3.5 years. Participants are Japanese and foreign residents living in the intervention and control regions (a total of population of 2,120,000 individuals).
The present study is designed to evaluate the effectiveness of the community-based suicide prevention program in the seven participating areas.
UMIN Clinical Trials Registry (UMIN-CTR) UMIN000000460.